Saturday - December 21, 2024

Spiro-Lactam NMDA Receptor Modulators and Uses Thereof

2024-12-17

ALEXANDRIA, Virginia, Dec. 17 -- TENACIA BIOTECHNOLOGY (HONG KONG) CO., LIMITED, Hong Kong, China has been assigned a patent (No. US 12167998 B2, initially filed June 24, 2021) developed by John A. Lowe, III, Stonington, Connecticut, and M. Amin Khan, Evanston, Illinois, for "Spiro-lactam NMDA receptor modulators and uses thereof." . . .

Information Request Form

Name:
Category that best fits the type of business or agency you are affiliated with:	Government Newspaper / Media Business Public Policy Individual / Student Educators
Company Name:
Email:
Phone:
State:

I'd like to have a copy of this article mailed to me.

To also receive a free sample of other Targeted News products check the appropriate boxes below.
Golf Handicap site (FairwayFiles.com)
Products marked with ** can be customized by keywords or areas of interest. If you select them please specify your keywords in the box below:

If we need to contact you please specify your preferred contact method. Have a representative contact me by phone
Have a representative contact me via email

Additonal questions or comments:

Click here for more information or a free trial

Existing Customer Login

Spiro-Lactam NMDA Receptor Modulators and Uses Thereof

Information Request Form

Copyright Targeted News Service 2024